Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium-free medium

Author： Rossoni G.   Locatelli V.   Gennaro Colonna V.d.   Müller E.E.   Berti F.  

Publisher： Academic Press

ISSN： 1043-6618

Source： Pharmacological Research, Vol.42, Iss.2, 2000-08, pp. : 129-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Growth hormone secretagogue receptor antagonists

By Costantino Luca  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 6, 2012-06 ,pp. : 697-700

Informa Healthcare

Access to resources Recommend Favorite

Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release

By Torsello A.   Luoni M.   Schweiger F.   Grilli R.   Guidi M.   Bresciani E.   Deghenghi R.   Muller E.E.   Locatelli V.  

European Journal of Pharmacology, Vol. 360, Iss. 2, 1998-11 ,pp. : 123-129

Elsevier

Access to resources Recommend Favorite

The Growth Hormone Secretagogue Receptor (Ghs-R)

By  

Current Pharmaceutical Design, Vol. 18, Iss. 31, 2012-10 ,pp. : 4749-4754

Bentham Science Publishers

Access to resources Recommend Favorite

The prospects of antagonizing the growth hormone secretagogue receptor to treat obesity

By Zhao Hongyu   Serby Michael D   Liu Bo  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 9, 2008-09 ,pp. : 989-998

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of P-selectin attenuates neutrophil-mediated myocardial dysfunction in isolated rat heart

By Ohnishi M.   Yamada K.   Morooka S.   Tojo S.J.  

European Journal of Pharmacology, Vol. 366, Iss. 2, 1999-02 ,pp. : 271-279

Elsevier

Access to resources Recommend Favorite